On October 22, Aimed Alliance published a new resource on the 340B Drug Pricing Program (340B Program). The 340B program is a federal program designed to help “covered entities” serving low-income and uninsured patients stretch their financial resources by purchasing prescription drugs at substantially discounted prices. In recent years, the 340B Program has come under scrutiny as certain covered entities are expanding the 340B Programs beyond eligible individuals and intended communities.
While there are widespread concerns about the management and oversight of the 340B Program, advocates have struggled to understand the various elements of this program and the reforms that are being proposed. As such, this resource intends to educate stakeholders on the elements of the 340B program and how the various reforms would impact diverse health care stakeholders such as patients, providers, and covered entities.
Last Updated on October 23, 2025 by Aimed Alliance
